Use of psychotropic medications in treating mood disorders during lactation: Practical recommendations

CNS Drugs

Volumn 20, Issue 3, 2006, Pages 187-198

  Eberhard Gran, Malin ^a   Eskild, Anne ^a,b   Opjordsmoen, Stein ^b  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CARBAMAZEPINE; CITALOPRAM; CLOZAPINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; LAMOTRIGINE; LITHIUM; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; OLANZAPINE; PAROXETINE; PSYCHOTROPIC AGENT; QUETIAPINE; REBOXETINE; RISPERIDONE; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE; ZIPRASIDONE; ZOLPIDEM; ZOPICLONE;

CLINICAL TRIAL; DRUG EXCRETION; GASTROINTESTINAL SYMPTOM; HUMAN; IRRITABILITY; MEDICAL LITERATURE; MOOD DISORDER; NEPHROTOXICITY; NEUROTOXICITY; PATHOLOGICAL CRYING; PRIORITY JOURNAL; PUERPERIUM; REVIEW; SIDE EFFECT; SLEEP DISORDER; THYROID DISEASE;

EID: 33644975242     PISSN: 11727047     EISSN: 11727047     Source Type: Journal    
DOI: 10.2165/00023210-200620030-00002     Document Type: Review

References (161)

1. Watson JP, Elliot SA, Rugg AJ. Psychiatric disorder in pregnancy and the first postnatal year. Br J Psychiatry 1984; 144: 453-62
2. Kumar R, Robson KM. A prospective study of emotional disorders in child-bearing women. Br J Psychiatry 1984; 144: 35-47
3. Hendrick V, Smith LM, Hwang S, et al. Weight gain in breastfed infants of mothers taking antidepressant medications. J Clin Psychiatry 2003; 64: 410-2
4. Moore G, Cohn J, Campbell S. Infant affective responses to mother's still face at 6 months differentially predict externalizing and internalizing behaviors at 18 months. Dev Psychol 2001; 37: 706-14
5. Sinclair D, Murray L. Effects of postnatal depression on children's adjustment to school. Br J Psychiatry 1998; 172: 58-63
6. Murray L, Sinclair D, Cooper PJ, et al. The socioemotional development of 5-year-old children of postnatally depressed mothers. J Child Psychol Psychiatry 1999; 40: 1259-71
7. Weinberg M, Tronick E. The impact of maternal psychiatric illness on infant development. J Clin Psychiatry 1998; 59: 53-61
8. Friel JK, Martin SM, Langdon M, et al. Milk from mothers of both premature and full-term infants provides better antioxidant protection than does infant formula. Pediatr Res 2002; 51: 612-8
9. A Joint WHO/UNICEF Statement. Protecting, promoting and supporting breastfeeding: the special role of maternity services. Geneva: WHO, 1989
10. American Academy of Pediatrics. Breastfeeding and the use of human milk. Pediatrics 1997; 100: 1035-9
11. Golding J, Emmett P, Rogers I. Gastroenteritis, diarrhoea and breast feeding. Early Hum Dev 1997; 49 Suppl.: s83-103
12. van Odijk J, Kull I, Borres M, et al. Breast feeding and allergic disease: a multidisciplinary review of the literature (1966-2001) on the mode of early feeding in infancy and its impact on later atopic manifestations. Allergy 2003; 58: 833-43
13. Foster S, Slade P, Wilson K. Body image, maternal fetal attachment, and breast feeding. J Psychosom Res 1996; 41: 181-4
14. Uvnas-Moberg K. Oxytocin may mediate the benefits of positive social interaction and emotions. Psychoneuroendocrinology 1998; 23: 819-35
15. Liestøl K, Rosenberg M, Walloe L. Breast-feeding practice in Norway 1860-1984. J Biosoc Sci 1988; 20: 45-58
16. Ryan AS, Wenjun Z, Acosta A. Breastfeeding continues to increase into the new millennium. Pediatrics 2002; 110: 1103-9
17. Newport D, Wilcox M, Stowe Z. Antidepressants during pregnancy and lactation: defining exposure and treatment issues. Semin Perinatol 2001; 25: 177-90
18. Wisner K, Perel J, Findling R. Antidepressant treatment during breast-feeding. Am J Psychiatry 1996; 153: 1132-7
19. Spigset O, Hagg S. Excretion of psychotropic drugs into breastmilk; pharmacokinetic overview and therapeutic implications. CNS Drugs 1998; 9 (2): 111-34
20. Misri S, Kostaras X. Benefits and risks to mother and infant of drug treatment for postnatal depression. Drug Saf 2002; 25: 903-11
21. Wisner K, Parry B, Piontek C. Postpartum depression. N Engl J Med 2002; 347: 194-9
22. Yoshida K, Smith B, Kumar R. Psychotropic drugs in mothers' milk: a comprehensive review of assay methods, pharmacokinetics and safety of breast-feeding. J Psychopharmacol 1999; 13: 64-80
23. Burt V, Suri R, Altshuler L, et al. The use of psychotropic medications during breast-feeding. Am J Psychiatry 2001; 158: 1001-9
24. Dodd S, Buist A, Norman T. Antidepressants and breast-feeding. Paediatr Drugs 2000; 2: 183-92
25. Hagg S, Spigset O. Anticonvulsant use during lactation. Drug Saf 2000; 22: 425-40
26. Hendrick V, Altshuler L. Management of major depression during pregnancy. Am J Psychiatry 2002; 159: 1667-73
27. Cox JL, Murray D, Chapman G. A controlled study of the onset, duration and prevalence of postnatal depression. Br J Psychiatry 1993; 163: 27-31
28. O MW, Swain AM. Rates and risk of postpartum depression: a meta-analysis. Int Rev Psychiatry 1996; 8: 37-54
29. Paykel E, Emms E, Fletcher J, et al. Life events and social support in puerperal depression. Br J Psychiatry 1980; 136: 339-46
30. Eberhard-Gran M, Eskild A, Tambs K, et al. Depression in postpartum and non-postpartum women: prevalence and risk factors. Acta Psychiatr Scand 2002; 105: 426-33
31. Eberhard-Gran M, Eskild A, Tambs K, et al. Review of validation studies of the Edinburgh Postnatal Depression Scale. Acta Psychiatr Scand 2001; 104: 243-9
32. Eberhard-Gran M, Tambs K, Opjordsmoen S, et al. Depression during pregnancy and after delivery: a repeated measurement study. J Psychosom Obstet Gynecol 2004; 25: 15-21
33. Evans J, Heron J, Francomb H, et al. Cohort study of depressed mood during pregnancy and after childbirth. BMJ 2001; 323: 257-60
34. O'Hara MW, Zekoski EM, Philipps LH, et al. Controlled prospective study of postpartum mood disorders: comparison of childbearing and nonchildbearing women. J Abnorm Psychol 1990; 99: 3-15
35. Johanson R, Chapman G, Murray L, et al. The North Staffordshire Maternity Hospital prospective study of pregnancy-associated depression. J Psychosom Obstet Gynaecol 2000; 21: 93-7
36. Josefsson A, Berg G, Nordin C, et al. Prevalence of depressive symptoms in late pregnancy and postpartum. Acta Obstet Gynecol Scand 2001; 80: 251-5
37. Eberhard-Gran M, Tambs K, Opjordsmoen S, et al. A comparison of anxiety and depressive symptomatology in puerperal and non-puerperal women. Soc Psychiatry Psychiatr Epidemiol 2003; 38: 551-6
38. Klein M, Essex MJ. Pregnant or depressed? The effect of overlap between symptoms of depression and somatic complaints of pregnancy on rates of major depression during second trimester. Depression 1994; 2: 1994-5
39. O'Hara MW, Neunaber DJ, Zekoski EM. Prospective study of postpartum depression: prevalence, course, and predictive factors. J Abnorm Psychol 1984; 93: 158-71
40. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression: development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987; 150: 782-6
41. Brockington I. Postpartum psychiatric disorders. Lancet 2004; 363: 303-10
42. O'Hara MW, Zekoski E. Postpartum depression: a comprehensive review. In: Kumar R, Brockington I, editors. Motherhood and mental illness. London: Wright, 1988: 17-63
43. First MB, Spitzer RL, Gibbon M, et al. Structural clinical interview for DSM-IV axis I disorders: patient edition (SCID I/P, version 2.0). New York: New York State Psychiatric Institute, Biometric Research Department, 1995
44. Emerson C. Thyroid diseases during and after pregnancy. In: Braverman J, editor. Werner and Ingbar's the thyroid. Philadelphia (PA): Lippincott Company, 1991: 1263-79
45. Learoyd D, Fung H, McGregor A. Postpartum thyroid dysfunction. Thyroid 1992; 2: 73-80
46. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: 4th ed. Washington (DC): American Psychiatric Press, 1994
47. Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord 1998; 50: 143-51
48. Brockington I, Cernick K, Schofield E, et al. Puerperal psychosis. Arch Gen Psychiatry 1981; 38: 829-33
49. Kendell RE, Chalmers JC, Platz C. Epidemiology of puerperal psychoses. Br J Psychiatry 1987; 150: 662-73
50. Bennazzi F. Mood patterns and classification in bipolar disorder. Curr Opin Psychiatry 2006; 19: 1-8
51. Breitzka R, Sandritter T, Hatzopoulus F. Principles of drug transfer into breastmilk and drug disposition in the nursing infant. J Hum Lact 1997; 13: 155-8
52. Jensen P, Olesen O, Bertelsen A, et al. Citalopram and desmethylcitalopram concentrations in breast milk and in serum of mother and infant. Ther Drug Monit 1997; 19: 236-9
53. Kacew S. Adverse effects of drugs and chemicals in breast milk on the nursing infant. J Clin Pharmacol 1993; 33: 213-21
54. Anderson PO, Pochop SL, Manoguerra AS. Adverse drug reactions in breastfed infants: less than imagined. Clin Pediatr 2003; 42: 325-40
55. Suri R, Stowe ZN, Hendrick V, et al. Estimates of nursing infant daily dose of fluoxetine through breast milk. Biol Psychiatry 2002; 52: 446-51
56. Stokes P, Holtz A. Fluoxetine tenth anniversary update: the progress continues. Clin Ther 1997; 19: 1135-250
57. Kristensen J, Ilett K, Hackett L, et al. Distribution and excretion of fluoxetine and norfluoxetine in human milk. Br J Clin Pharmacol 1999; 48: 521-7
58. Taddio A, Ito S, Koren G. Excretion of fluoxetine and its metabolite, norfluoxetine, in human breastmilk. J Clin Pharmacol 1996; 36: 42-7
59. Isenberg KE. Excretion of fluoxetine in human breast milk [letter]. J Clin Psychiatry 1990; 51: 169
60. Burch K, Wells B. Fluoxetine/norfluoxetine concentrations in human milk. Pediatrics 1992; 89: 676-7
61. Yoshida K, Smith B, Kumar R. Fluvoxamine in breast-milk and infant development. Br J Clin Pharmacol 1997; 44: 210-1
62. Wright S, Dawling S, Ashford J. Excretion of fluvoxamine in breast milk [letter]. Br J Clin Pharmacol 1991; 31: 209
63. Begg E, Duffull SB, Saunders DA, et al. Paroxetine in human milk. Br J Clin Pharmacol 1999; 48: 142-7
64. Stowe Z, Cohen L, Hostetter A, et al. Paroxetine in human breast milk and nursing infants. Am J Psychiatry 2000; 157: 185-9
65. Misri S, Kim J, Riggs K, et al. Paroxetine levels in postpartum depressed women, breast milk, and infant serum. J Clin Psychiatry 2000; 61: 828-32
66. Ohman R, Hagg S, Carleborg L, et al. Excretion of paroxetine into breast milk. J Clin Psychiatry 1999; 60: 519-23
67. Spigset O, Carleborg L. Paroxetine level in breast milk [letter]. J Clin Psychiatry 1996; 57: 39
68. Rampono J, Kristensen J, Hackett L, et al. Citalopram and demethylcitalopram in human milk; distribution, excretion and effects in breast fed infants. Br J Clin Pharmacology 2000; 50: 263-8
69. Schmidt K, Olesen O, Jensen P. Citalopram and breastfeeding: serum concentration and side effects in the infant. Biol Psychiatry 2000; 47: 164-5
70. Spigset O, Carleborg L, Ohman R, et al. Excretion of citalopram in breast milk. Br J Clin Pharmacol 1997; 44: 236-9
71. Kristensen J, Ilett K, Dusci L, et al. Distribution and excretion of sertraline and N-desmethylsertraline in human milk. Br J Clin Pharmacol 1998; 45: 453-7
72. Stowe Z, Owens M, Landry J, et al. Sertraline and desmethylsertraline in human breast milk and nursing infants. Am J Psychiatry 1997; 154: 1255-60
73. Hagg S, Granberg K, Carleborg L. Excretion of fluvoxamine into breast milk. Br J Clin Pharmacol 2000; 49: 283-8
74. Kristensen J, Hackett L, Kohan R, et al. The amount of fluvoxamine in milk is unlikely to be a cause of adverse effects in breastfed infants. J Hum Lact 2002; 18: 139-43
75. Altamura A, Moro A, Percudani M. Clinical pharmacokinetics of fluoxetine. Clin Pharmacokinet 1994; 26: 201-14
76. Brent N, Wisner KL. Fluoxetine and carbamazepine concentrations in a nursing mother/infant pair. Clin Pediatr 1998; 37: 41-4
77. Lester B, Cucca J, Andreozzi B, et al. Possible association between fluoxetine hydrochloride and colic in an infant. J Am Acad Child Adolesc Psychiatry 1993; 32: 1253-5
78. Hale TW, Shum S, Grossberg M. Fluoxetine toxicity in a breastfed infant. Clin Pediatr 2005; 40: 681-4
79. Chambers C, Anderson P, Thomas R, et al. Weight gain in infants breastfed by mothers who take fluoxetine. Pediatrics 1999; 104: e61
80. Yoshida K, Smith B, Craggs M, et al. Fluoxetine in breast-milk and developmental outcome of breast-fed infants. Br J Psychiatry 1998; 172: 175-9
81. Birnbaum C, Cohen L, Bailey J, et al. Serum concentrations of antidepressants and benzodiazepines in nursing infants: a case series. Pediatrics 1999; 104: e11
82. Berle JO, Steen VM, Aamo TO, et al. Breastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors: infant exposure, clinical symptoms, and cytochrome p450 genotypes. J Clin Psychiatry 2004; 65: 1228-34
83. Hendrick V, Fukuchi A, Altshuler L, et al. Use of sertraline, paroxetine and fluvoxamine by nursing women. Br J Psychiatry 2001; 179: 163-6
84. Altshuler L, Burt V, McMullen M, et al. Breastfeeding and sertraline: a 24-hour analysis. J Clin Psychiatry 1995; 56: 243-5
85. Epperson C, Anderson G, McDougle C, et al. Sertraline and breastfeeding. N Engl J Med 1997; 336: 1189-90
86. Mammen O, Perel J, Rudolph G, et al. Sertraline and norsertraline levels in three breastfed infants. J Clin Psychiatry 1997; 58: 100-3
87. Wisner K, Perel J, Blumer J. Serum sertraline and N-desmethylsertraline levels in breast-feeding mother-infant pairs. Am J Psychiatry 1998; 155: 690-2
88. Dodd S, Stocky A, Buist A, et al. Sertraline in paired blood plasma and breast-milk samples from nursing mothers. Hum Psychopharmacol 2000; 15: 261-4
89. Stowe Z, Hostetter A, Owens M, et al. The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentration. J Clin Psychiatry 2003; 64: 73-80
90. Epperson N, Czarkowski KA, Ward-O'Brien D, et al. Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs. Am J Psychiatry 2001; 158: 1631-7
91. Piontek C, Wisner K, Perel J, et al. Serum fluvoxamine levels in breastfed infants. J Clin Psychiatry 2001; 62: 111-3
92. Brixen-Rasmussen L, Halgrener J, Jorgensen A. Amitriptyline and nortriptyline excretion in human breast milk. Psychopharmacology 1982; 76: 94-5
93. Breyer-Pfaff U, Nill K, Entemann A, et al. Secretion of amitriptyline and metabolites into breast milk. Am J Psychiatry 1995; 152: 812-3
94. Wisner K, Perel J. Serum nortriptyline levels in nursing mothers and their infants. Am J Psychiatry 1991; 148: 1234-6
95. Wisner K, Perel J. Nortriptyline treatment of breast-feeding women [letter]. Am J Psychiatry 1996; 153: 295
96. Stancer H, Reed K. Desipramine and 2-hydroxydesipramine in human breast milk and the nursing infant's serum. Am J Psychiatry 1986; 143: 1595-600
97. Schimmell M, Katz E, Shaag Y, et al. Toxic neonatal effects following maternal clomipramine therapy. J Toxicol Clin Toxicol 1991; 29: 479-84
98. Wisner K, Perel J, Foglia J. Serum clomipramine and metabolite levels in four nursing mother-infant pairs. J Clin Psychiatry 1995; 56: 17-20
99. Ilett K, Lebedevs T, Wojnar-Horton R, et al. The excretion of dothiepin and its primary metabolites in breast milk. Br J Clin Pharmacol 1992 Jun; 33 (6): 635-9
100. Matheson I, Pande H, Alertsen A. Respiratory depression caused by N-desmethyldoxepin in breast milk [letter]. Lancet 1985; II: 1124
101. Kemp J, Ilett K, Booth J, et al. Excretion of doxepin and N-desmethyldoxepin in human milk. Br J Clin Pharmacol 1985; 20: 497-9
102. Frey O, Scheidt P, von Brenndorff A. Adverse effects in a newborn infant breast-fed by a mother treated with doxepin. Ann Pharmacother 1999; 33: 690-3
103. Misri S, Sivertz K. Tricyclic drugs in pregnancy and lactation: a preliminary report. Int J Psychiatry Med 1991; 21: 157-71
104. Buist A, Janson H. Effect of exposure to dothiepin and northiaden in breast milk on child development. Br J Psychiatry 1995; 167: 370-3
105. Yoshida K, Smith B, Craggs M, et al. Investigation of pharmacokinetics and of possible adverse effects in infants exposed to tricyclic antidepressants in breast-milk. J Affect Disord 1997; 43: 225-37
106. Ilett K, Hackett L, Dusci L. Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk. Br J Clin Pharmacol 1998; 45: 459-62
107. Ilett K, Kristensen J, Hackett L, et al. Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants. Br J Clin Pharmacol 2002; 53: 17-22
108. Hendrick V, Altshuler L, Wertheimer A, et al. Venlafaxine and breast-feeding. Am J Psychiatry 2001; 158: 2089-90
109. Verbeeck RK, Ross SG, McKenna EA. Excretion of trazodone in breast milk. Br J Clin Pharmacol 1986; 22: 367-70
110. Dodd S, Buist A, Burrows G, et al. Determination of nefazodone and its pharmacologically active metabolites in human blood plasma and breastmilk by high-performance liquid chromatography. J Chromatogr B 1999; 730: 249-55
111. Yapp P, Ilett K, Kristensen J, et al. Drowsiness and poor feeding in a breast-fed infant: association with nefazodone and its metabolites. Ann Pharmacother 2000; 34: 1269-72
112. Pons G, Schoerlin MP, Tam YK, et al. Maclobemide excretion in human breast milk. Br J Clin Pharmacol 1990; 29: 27-31
113. Patrick MJ, Tilstone WJ, Reavey P. Diazepam and breast-feeding. Lancet 1972; I: 542-3
114. Wesson DR, Cambers S, Harkey M, et al. Diazepam and desmethyldiazepam in breast milk. J Psychoactive Drugs 1985; 17: 55-6
115. Pons G, Francoual C, Guillet PH, et al. Zolpidem excretion in breast milk. Eur J Clin Pharmacol 1989; 37: 245-8
116. Matheson I, Sande HA, Gaillot J. The excretion of zopiclone into breast milk. Br J Clin Pharmacol 1990; 30: 267-71
117. Tunnessen WW, Hertz CG. Toxic effects of lithium in newborn infants: a commentary. J Pediatr 1972; 81: 804-7
118. Amdsen A. Clinical features and management of lithium poisoning. Med Toxicol Adverse Drug Exp 1988; 3: 18-32
119. Llewellyn A, Stowe ZN, Strader JR. The use of lithium and management of women with bipolar disorder during pregnancy and lactation. J Clin Psychiatry 1998; 59 Suppl. 6: 57-64
120. Schou M. Lithium treatment during pregnancy, delivery, and lactation: an update. J Clin Psychiatry 1990; 51: 410-3
121. Pynnonen S, Kanto J, Sillanpaa M, et al. Carbamazepine: placental transport, tissue concentrations in foetus and newborn, and level in milk. Acta Pharmacol Toxicol 1977; 41: 244-53
122. Niebyl JR, Blake DA, Freeman JM, et al. Carbamazepine levels in pregnancy and lactation. Obstet Gynecol 1979; 53: 139-40
123. Kaneko S, Sato T, Susuki K. The levels of anticonvulsants in breast milk. Br J Clin Pharmacol 1979; 7: 624-7
124. Kaneko S, Susuki K, Sato T. The problems of antiepileptic medication in the neonatal period: is breast feeding advisable. In: Janz D, editor. Epilepsy, pregnancy and the child. New York: Raven Press, 1982: 343-8
125. Shimoyama R, Ohkubo T, Sugawara K. Monitoring of carbamazepine and carbamazepine 10,11-epoxide in breast milk and plasma by high-performance liquid chromatography. Ann Clin Biochem 2000; 37: 210-5
126. Piontek C, Baab S, Peindl K, et al. Serum valproate levels in 6 breastfeeding mother-infant pairs. J Clin Psychiatry 2000; 61: 170-2
127. Nau H, Helge H, Luck W. Valproic acid in the perinatal period: decreased maternal serum protein binding results in fetal accumulation and neonatal displacement of the drug and some metabolites. J Pediatr 1984; 104: 627-34
128. von Unruh GE, Froescher W, Hoffmann F, et al. Valproic acid in breast milk: how much is really there? Ther Drug Monit 1984; 6: 272-6
129. Wisner KL, Perel JM. Serum levels of valproate and carbamazepine in breastfeeding mother-infant pairs. J Psychopharmacol 1998; 18: 167-9
130. Frey B, Schubiger G, Musy JP. Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breast-feeding. Eur J Pediatr 1990; 150: 136-8
131. Stahl MM, Neiderud J, Vinge E. Thrombocytopenic purpura and anemia in a breast-fed infant whose mother was treated with valproic acid. J Pediatr 1997; 130: 1001-3
132. Liporace J, Kao A, D'Abreu A. Concerns regarding lamotrigine and breast-feeding. Epilepsy Behav 2004; 5: 102-5
133. Ohman I, Vitols S, Tomson T. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia 2000; 41: 709-13
134. Tomson T, Ohman I, Vitols S. Lamotrigine in pregnancy and lactation: a case report. Epilepsia 1997; 38: 1039-41
135. Yatham LN. Acute and maintenance treatment of bipolar mania: the role of atypical antipsychotics. Bipolar Disord 2003; 5 Suppl. 2: 7-19
136. Fenton C, Scott LJ. Risperidone: a review of its use in the treatment of bipolar mania. CNS Drugs 2005; 19 (5): 429-44
137. Barnas C, Bergant A, Hummer M, et al. Clozapine concentrations in maternal and fetal plasma, amniotic fluid and breast milk [letter]. Am J Psychiatry 1994; 151: 945
138. Croke S, Buist A, Hackett L, et al. Olanzapine excretion in human breast milk: estimation of infant exposure. Int J Neuropsychopharmacol 2002; 5: 243-7
139. Hill RC, McIvor RJ, Wojnar-Horton R, et al. Risperidone distribution and excretion into human milk: case report and estimated infant exposure during breast-feeding. J Clin Psychopharmacol 2000; 20: 285-6
140. Ilett KF, Hackett L, Kristensen J, et al. Transfer of risperidone and 9-hydroxyrisperidone into human milk. Ann Pharmacother 2004; 38: 273-6
141. Goldstein D, Corbin L, Fung MC. Olanzapine-exposed pregnancies and lactation: early experiences. J Psychopharmacol 2000; 20: 399-403
142. Kirchheiner J, Berghøfer A, Bolk-Weischedel D. Healthy outcome under olanzapine treatment in a pregnant woman. Pharmacotherapy 2000; 33: 78-80
143. Gardiner SJ, Kristensen J, Begg E, et al. Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants. Am J Psychiatry 2003; 160: 1428-31
144. Spigset O, Ḧagg S. Excretion of psychotropic drugs into breast milk: pharmacokinetic overview and therapeutic implications. CNS Drugs 1998; 9 (2): 111-34
145. Heikkinen T, Ekblad U, Palo P, et al. Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation. Clin Pharmacol Ther 2003; 73: 330-7
146. Sharma V. Pharmacotherapy of postpartum depression. Expert Opin Pharmacother 2002; 3: 1421-31
147. Holden J, Sagovsky R, Cox J. Counseling in a general practice setting: a controlled study of health visitor intervention in treatment of postnatal depression. BMJ 1989; 298: 223-6
148. Wickberg B, Hwang C. Counselling of postnatal depression: a controlled study on a population based Swedish sample. J Affect Disord 1996; 39: 209-16
149. Dennis CL. Treatment of postpartum depression, part 2: a critical review of nonbiological interventions. J Clin Psychiatry 2004; 65: 1252-65
150. Ray K, Hodnett E. Caregiver support for postpartum depression. Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 3. Oxford: Update Software, 2002
151. Misri S, Kostaras X, Fox D, et al. The impact of partner support in the treatment of postpartum depression. Can J Psychiatry 2000; 45: 554-8
152. MacArthur C, Winter H, Bick D, et al. Effects of redesigned community postnatal care on womens' health 4 months after birth: a cluster randomised controlled trial. Lancet 2002; 359: 378-85
153. O'Hara M, Stuart S, Gorman L, et al. Efficacy of interpersonal psychotherapy for postpartum depression. Arch Gen Psychiatry 2000; 57: 1039-45
154. Klier C, Muzik M, Rosenblum K, et al. Interpersonal psychotherapy adapted for the group setting in the treatment of postpartum depression. J Psychother Pract Res 2003; 10: 124-31
155. Appleby L, Warner R, Whitton A, et al. A controlled study of fluoxetine and cognitive-behavioral counselling in the treatment of postnatal depression. BMJ 1997; 314: 932-6
156. Dennis C-L, Stewart D. Treatment of postpartum depression, part 1: a critical review of biological interventions. J Clin Psychiatry 2004; 65: 1242-51
157. Reed P, Sermin N, Appleby L, et al. A comparison of clinical response to electroconvulsive therapy in puerperal and non puerperal psychoses. J Affect Disord 1999; 54: 255-60
158. Pons G, Rey E, Matheson I. Excretion of psychoactive drugs into breast milk: pharmacokinetic principles and recommendations. Clin Pharmacokinet 1994; 27: 270-89
159. Wretlind M. Excretion of oxazepam in breastmilk. Eur J Clin Pharmacol 1987; 33: 209-10
160. Chaudron L, Jefferson J. Mood stabilizers during breastfeeding: a review. J Clin Psychiatry 2000; 61: 79-90
161. Sharma V, Smith A, Khan M. The relationship between duration of labour, time of delivery, and puerperal psychosis. J Affect Disord 2004; 82: 215-20